Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Total Costs & Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+12.3%
5Y CAGR+15.4%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+12.3%/yr
vs +51.3%/yr prior
5Y CAGR
+15.4%/yr
Recent deceleration
Acceleration
-39.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$948.36M+0.2%
2024$946.35M+3.6%
2023$913.71M+36.4%
2022$670.03M+11.1%
2021$602.84M+29.8%
2020$464.37M+61.2%
2019$288.02M+125.1%
2018$127.92M+152.0%
2017$50.77M+86.1%
2016$27.28M-